We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M Turnover 17.39%
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+8.66%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$176M
AUM Growth
+$11.8M
Cap. Flow
+$3.11M
Cap. Flow %
1.76%
Top 10 Hldgs %
67.24%
Holding
79
New
13
Increased
10
Reduced
24
Closed
26
Avg Time Held Equity + Options
1 year
Top 10 Avg Time Held Equity + Options
1.3 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
1.2 years
Top 10 Avg Time Held Equity only
1.3 years
Top 20 Avg Time Held Equity only
1.2 years

Sector Composition

Rank Sector Weight
1 Healthcare 46.65%
2 Financials 21.92%
3 Miscellaneous 8.45%
4 Materials 6.36%
5 Communication Services 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FOMX
1
DELISTED
Foamix Pharmaceuticals
FOMX
$17.3M 9.82%
1,560,000
-107,377
-6% -$1.01M
2014 Q3
9 quarters
JPM icon
2
JPMorgan Chase
JPM
$850B
$13.6M 7.71%
157,606
-328
-0.2% -$25K
2016 Q1
3 quarters
GS icon
3
Goldman Sachs
GS
$246B
$13.2M 7.49%
55,168
-9
-0% -$1.83K
2015 Q3
5 quarters
CAH icon
4
Cardinal Health
CAH
$63B
$13M 7.35%
180,000
-220
-0.1% -$15.9K
2013 Q2
14 quarters
CVS icon
5
CVS Health
CVS
$102B
$12M 6.79%
151,750
-159
-0.1% -$12.9K
2013 Q2
14 quarters
HCA icon
6
HCA Healthcare
HCA
$96.6B
$11.9M 6.74%
160,462
+54,831
+52% +$4.11M
2014 Q4
8 quarters
BERY icon
7
DELISTED
Berry Global Group
BERY
$11.2M 6.36%
250,470
– –
2015 Q3
5 quarters
NSTG
8
DELISTED
NanoString Technologies
NSTG
$10.4M 5.88%
465,000
– –
2015 Q2
6 quarters
AET
9
DELISTED
Aetna Inc
AET
$10.2M 5.8%
82,536
+37,373
+83% +$4.47M
2016 Q2
2 quarters
IWN icon
10
iShares Russell 2000 Value ETF
IWN
$13.4B
$5.84M 3.31%
49,080
+37,320
+317% +$4.12M
2016 Q3
1 quarter
PARA icon
11
DELISTED
Paramount Global Class B
PARA
$5.41M 3.07%
85,000
– –
2015 Q4
4 quarters
APTV icon
12
Aptiv
APTV
$7.6B
$5.05M 2.86%
75,000
– –
2016 Q1
3 quarters
PFNX
13
DELISTED
Pfenex
PFNX
$4.63M 2.62%
510,000
– –
2014 Q3
9 quarters
IWO icon
14
iShares Russell 2000 Growth ETF
IWO
$13.3B
$4.58M 2.6%
29,740
+15,580
+110% +$2.33M
2016 Q3
1 quarter
TEL icon
15
TE Connectivity
TEL
$60.7B
$4.36M 2.48%
63,000
– –
2016 Q2
2 quarters
ZVRA icon
16
Zevra Therapeutics
ZVRA
$537M
$4.3M 2.44%
91,200
+32,232
+55% +$1.98M
2015 Q2
6 quarters
NEOS
17
DELISTED
Neos Therapeutics
NEOS
$4.06M 2.3%
693,582
-91,122
-12% -$617K
2015 Q3
5 quarters
HRI icon
18
Herc Holdings
HRI
$5.11B
$2.71M 1.54%
67,500
+21,241
+46% +$767K
2016 Q3
1 quarter
SPY icon
19
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$763B
$2.61M 1.48%
2,000,000
+340,700
+21% +$74.4M
2014 Q1
11 quarters
SWFT
20
DELISTED
Swift Transportation
SWFT
$2.44M 1.38%
+100,000
New +$2.33M
2016 Q4
0 quarters
AMGN icon
21
Amgen
AMGN
$238B
$2.23M 1.27%
15,274
-57
-0.4% -$8.58K
2013 Q2
14 quarters
LBTYA icon
22
Liberty Global Class A
LBTYA
$3.34B
$1.9M 1.08%
+90,000
New +$2.84M
2016 Q4
0 quarters
ATH
23
DELISTED
Athene Holding
ATH
$1.2M 0.68%
+25,000
New +$1.16M
2016 Q4
0 quarters
XBI icon
24
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.8B
$1.14M 0.65%
+500,000
New +$30.9M
2016 Q4
0 quarters
VCEL icon
25
Vericel
VCEL
$2.96B
$1.09M 0.62%
+363,569
New +$935K
2016 Q4
0 quarters

Similar funds

DSC Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, DSC Advisors held 79 positions worth $176M, up 7.2% from $165M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

DSC Advisors's Q4 2016 filing shows 13 new, 10 increased, 24 reduced and 26 closed positions. Its largest new stake was Liberty Global Class A: 90,000 shares worth $1.9M. The largest sale was Elevance Health, an estimated $5.7M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 55% a quarter earlier, followed by Financials and Miscellaneous.

  • DSC Advisors's largest Q4 2016 buy was Liberty Global Class A: 90,000 shares worth $1.9M.
  • DSC Advisors added most to Aetna Inc in Q4 2016, an estimated $4.47M increase.
  • DSC Advisors's biggest Q4 2016 reduction was Foamix Pharmaceuticals, cutting an estimated $1.01M.
  • DSC Advisors fully exited Elevance Health in Q4 2016, selling an estimated $5.7M.
  • DSC Advisors's ten largest holdings make up 67% of its $176M portfolio in Q4 2016.
  • DSC Advisors opened 13 new positions and closed 26 in Q4 2016.
  • DSC Advisors's portfolio value rose 7.2% quarter-over-quarter to $176M.

Based on DSC Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.